Physician profile
Ashley Resetarits
NPI 1023552940
$2,477.05
in general payments reported to CMS, 2019-2025
15 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $815 · 2023: $556 · 2024: $322 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.99 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $414.17 | 2021-2024 | Lokelma |
| Medtronic, INC. | $290.71 | 2022-2025 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $287.47 | 2021-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $253.41 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Boston Scientific Corporation | $217.47 | 2023 | Zoom Wireless Transmitter, Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.12 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $157.62 | 2023-2025 | |
| Esperion Therapeutics, INC. | $157.40 | 2021-2022 | |
| Chiesi USA, INC. | $130.29 | 2025 | Kengreal |
| Pfizer INC. | $105.43 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $97.40 | 2022-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $71.39 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $57.09 | 2022-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $20.75 | 2025 | |
| Abbott Laboratories | $14.33 | 2024 | Jot Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Resetarits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.